ABOUT CORDENPHARMA

Full-Service CDMO for a Global Market


Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides, Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules - Antibiotics – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.

  • >> Full-Service CDMO Organized under 5 Technology Platforms
  • >> 8 cGMP Manufacturing Facilities in Europe / US and 1 R&D Research Laboratory
  • >> 1,570 Employees
 

CordenPharma Mission

CordenPharma is a full-service partner in the cGMP Contract Development & Manufacturing of Active Pharmaceutical Ingredients (APIs), Drug Products and Pharma Packaging Services, supporting leading pharmaceutical & biotechnology companies to achieve product success for their patients’ healthier lives.

 

CordenPharma Acquisition History by ICIG


CordenPharma FacilityLegacy CompanyYear Acquired
CordenPharma ChenôveAbbott / Solvay12 / 2007
CordenPharma PlankstadtAstraZeneca1 / 2008
CordenPharma CaponagoAstraZeneca6 / 2009
CordenPharma Latina*Bristol-Myers Squibb5 / 2010
CordenPharma SwitzerlandSanofi / Genzyme2 / 2011
CordenPharma ColoradoRoche8 / 2011
CordenPharma BergamoTessenderlo / Farchemia12 / 2012
CordenPharma BrusselsSolvay / Peptisyntha11 / 2013
CordenPharma BoulderPfizer / Hospira10 / 2017

*CordenPharma Latina is owned by Financière Victoire S.A. as of 2018